In this study, we evaluated the anti-cancer effect of CB13 (a novel PPARγ agonist candidate) and investigated the role of PPARɣ, ROS, exosomes, and ER stress in CB13-induced cell death in human NSCLC and radio-resistant NSCLC cells. The gene discussed is PPARA; the disease is non-small cell lung carcinoma.